The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dosing tolerability and adverse events (AEs) in dihydropyrimidine dehydrogenase (DPYD) variant carriers receiving genotyping-guided fluoropyrimidine (FP) dosing.
 
Grace Nguyen
No Relationships to Disclose
 
Sarah Morris
No Relationships to Disclose
 
Simeon Kwange
No Relationships to Disclose
 
Annabel Chen
No Relationships to Disclose
 
Alicia Hamilton
Employment - Atrium Health
 
Nury Steuerwald
Employment - Atrium Health
Research Funding - Atrium Health
Patents, Royalties, Other Intellectual Property - I hold a patent for a gene signature predictive of outcome in drug induced liver injury. I have not received any royalties to date from this patent.
Travel, Accommodations, Expenses - Atrium Health
 
Donald Moore
Consulting or Advisory Role - Genentech; GlaxoSmithKline; Incyte; Sanofi
 
Sarah Hanson
No Relationships to Disclose
 
Laura Musselwhite
No Relationships to Disclose
 
Kunal Kadakia
No Relationships to Disclose
 
Jimmy Hwang
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Caris Centers of Excellence; Ipsen
 
Jai Patel
Honoraria - Clarified Precision Medicine; VieCure
Consulting or Advisory Role - Clarified Precision Medicine; VieCure
Research Funding - American Association for Cancer Research (Inst); Bristol-Myers Squibb (Inst); Professional Compounding Centers of America (Inst); Symberix (Inst); WinSanTor (Inst)